Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Share-based Compensation (2023 - 2025)

Historic Share-based Compensation for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to $1.0 million.

  • Rallybio's Share-based Compensation fell 4834.73% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year decrease of 2419.86%. This contributed to the annual value of $8.0 million for FY2024, which is 2680.4% down from last year.
  • Per Rallybio's latest filing, its Share-based Compensation stood at $1.0 million for Q3 2025, which was down 4834.73% from $1.6 million recorded in Q2 2025.
  • Rallybio's 5-year Share-based Compensation high stood at $3.0 million for Q1 2023, and its period low was $1.0 million during Q3 2025.
  • For the 3-year period, Rallybio's Share-based Compensation averaged around $2.1 million, with its median value being $2.0 million (2024).
  • Over the last 5 years, Rallybio's Share-based Compensation had its largest YoY gain of 1000.96% in 2025, and its largest YoY loss of 4834.73% in 2025.
  • Rallybio's Share-based Compensation (Quarter) stood at $2.5 million in 2023, then decreased by 22.99% to $2.0 million in 2024, then crashed by 46.66% to $1.0 million in 2025.
  • Its Share-based Compensation was $1.0 million in Q3 2025, compared to $1.6 million in Q2 2025 and $1.9 million in Q1 2025.